2020 Revenues ($USD) : $7,369,357,558 2020 Revenues (foreign currencies) : JP¥786,900,000,000 2020 R&D spend : not available 2020 Number of Employees : 7,555 Fiscal Year End : 12/31/2020 Key People : Osamu Okuda, CEO
Under a strategic alliance forged with Roche in 2002, Chugai maintained management independence while gaining the exclusive right to market Roche's products in Japan. Chugai also has access to the Roche Group's research infrastructure and global platform. Chugai boasts unique antibody engineering technologies as it continues to refine its scientific and technological strengths. –CN